News and events
View from the top: closerlook once again selected as an MM&M Top 100 Agency
Medical Marketing and Media--July 2015
We’re honored to announce that closerlook has once again been named a Medical Marketing & Media (MM&M) Top 100 Agency in 2015. CEO David Ormesher and President/COO Jon Sawyer spoke with MM&M recently about our work over the past year, and what we’re planning for 2015 and beyond.
We’ve continued making strides in bringing customer intelligence and customer access together to help pharmaceutical marketers build better relationships with their customers. “It’s not just about using software and email campaigns but about using data to make better decisions about where to put the money,” says Sawyer. With this in mind, we’ve expanded our strategy and analytics departments; and, as always, we’ve continued cultivating a collaborative culture where experts in strategy, analytics, creative, technology and client service can work together in-house to deliver a range of technology-enabled offerings.
This has allowed us to simplify our offerings into digestible phases, so that clients can confidently implement relationship marketing within their organizations. We’ve launched the Target ClarityTM HCP Adoption Analysis platform to arm marketers with insight about which targets to grow, maintain or from which to divest. We’ve also expanded our proprietary Backstage® Relationship Marketing Technology Suite to offer seamless synthesis of data management, customer experience, and the efforts of Sales Representatives in the field.
“Unlike other agencies, we have the integration between competencies, and work to continually improve on it,” Ormesher says. And in the coming year, it’s that integration and collaboration that will enable us to continue bringing practical innovation to a changing industry—and help our clients meet the challenge of transitioning further into the digital world.
The drugs, Optistavin, Easovartis and Librylin, and names, results, case studies and specific information, referenced in this advertisement are fictional and were created solely for illustrating the digital marketing capabilities of closerlook, inc. Any resemblance to actual drugs, medications, treatments, persons, living or dead, or to actual events, is purely coincidental. closerlook, inc. does not assume and hereby disclaims any liability to any party for any loss, damage or disruption caused by such party’s reliance on the fictitious information contained in this illustration.